| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 11/01/2001 | CA2407083A1 Apo-ai/aii peptide derivatives |
| 11/01/2001 | CA2406532A1 Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus compri sing alkyl and aryl alanine p2 moieties |
| 10/31/2001 | EP1149906A1 Thrombopoietin receptor modulating peptide |
| 10/31/2001 | EP1149111A1 Method and composition for angiogenesis inhibition |
| 10/31/2001 | EP0833652A4 Novel kappa receptor selective opioid peptides |
| 10/31/2001 | EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications |
| 10/30/2001 | US6310189 Nucleotides and analogs having photoremoveable protecting groups |
| 10/30/2001 | US6310180 Method for synthesis of proteins |
| 10/30/2001 | US6310177 Compounds and methods for modulating tissue permeability |
| 10/30/2001 | US6310176 Antimicrobially active polypeptides |
| 10/30/2001 | US6310041 For treatment of eye disease selected from alkali-injured eye, chemically injured eye and inflammatory disease of the eye |
| 10/30/2001 | US6310040 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs |
| 10/30/2001 | US6309642 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
| 10/30/2001 | CA2052375C Parathyroid hormone derivatives |
| 10/25/2001 | WO2001079479A2 Methods for selective targeting |
| 10/25/2001 | WO2001079286A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 10/25/2001 | WO2001079268A2 A glycopeptide and preparation thereof |
| 10/25/2001 | WO2001079267A2 A glycopeptide and preparation thereof |
| 10/25/2001 | WO2001079266A1 Antibody against human kgfr |
| 10/25/2001 | WO2001079265A1 Antibody against human kgf |
| 10/25/2001 | WO2001079263A1 Peptide derivatives and medicinal compositions |
| 10/25/2001 | WO2001079242A2 Process for preparing lipid ii and derivatives thereof |
| 10/25/2001 | WO2001078767A2 Pharmaceutical preparations comprising modified peptides |
| 10/25/2001 | WO2000047618A9 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES |
| 10/25/2001 | US20010034326 Therapy for hematopoietic neoplasma |
| 10/25/2001 | US20010034035 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier |
| 10/25/2001 | US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2 |
| 10/25/2001 | CA2406953A1 A glycopeptide and preparation thereof |
| 10/25/2001 | CA2406952A1 Process for preparing lipid ii |
| 10/25/2001 | CA2406213A1 Compositions and methods for the therapy and diagnosis of breast cancer |
| 10/24/2001 | EP1147132A2 Antiviral peptides |
| 10/24/2001 | EP1147128A1 Binding molecules for human factor viii and factor viii-like proteins |
| 10/24/2001 | EP1147127A1 Volatilizable solid phase supports for compound synthesis |
| 10/24/2001 | EP0919567B1 Novel peptides and nootropic agent |
| 10/24/2001 | EP0820433B1 O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof |
| 10/24/2001 | EP0801686B1 Process for preparing cyclosporin a |
| 10/24/2001 | EP0721957B1 Compound ge3 |
| 10/24/2001 | EP0618802B1 Synthetic compounds and compositions with enhanced cell binding |
| 10/24/2001 | EP0593754B1 Peptides of human papilloma virus for use in human t cell response inducing compositions |
| 10/24/2001 | CN1319133A Short peptides which selectively modulate activity of protein kinases |
| 10/24/2001 | CN1319105A Methods for produsction of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 10/23/2001 | US6307017 Linear analog of biologically active mammalian gastrin-releasing peptide, amphibian bombesin, or mammalian growth hormone releasing factor; treatment of gastrointestinal disorders, diabetes, cancer |
| 10/23/2001 | US6307016 Broad-spectrum antimicrobial peptides effective against a wide variety of microbes, including bacteria; antibiotic peptides |
| 10/23/2001 | US6306822 Phosphopeptides and methods of treating bone diseases |
| 10/23/2001 | US6306663 Controlling protein levels in eucaryotic organisms |
| 10/23/2001 | US6306306 Chromatographic process for obtaining highly purified cyclosporin A and related cyclosporins |
| 10/23/2001 | CA2125043C Heparin- and sulfatide-binding peptides from the type i repeats of human thrombospondin |
| 10/23/2001 | CA2048407C Gonadoliberin antagonists |
| 10/18/2001 | WO2001077687A2 Prion-binding peptidic ligands and methods of using same |
| 10/18/2001 | WO2001077369A1 Fluorescence detection of proteases or peptidases |
| 10/18/2001 | WO2001077146A2 Compounds and methods for modulating endothelial cell adhesion |
| 10/18/2001 | WO2001077145A2 Integrin binding peptide derivatives |
| 10/18/2001 | WO2001077122A1 Ternary ligand complexes useful as radiopharmaceuticals |
| 10/18/2001 | WO2001077113A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 10/18/2001 | WO2001076636A2 Pharmaceutical composition of modified pna molecules |
| 10/18/2001 | WO2001076616A1 Tamandarin and didemnin analogs and methods of making and using them |
| 10/18/2001 | WO2001025264A3 Substituted phosphinate based peptide derivatives |
| 10/18/2001 | US20010031857 Memno peptides, process for their preparation and use thereof |
| 10/18/2001 | US20010031728 Fungicides |
| 10/18/2001 | US20010031476 Determining rate of bone resorption by measuring peptides in body fluid having 3-hydroxypyridinium cross-link; diagnostic tool for Paget's disease |
| 10/18/2001 | DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system |
| 10/18/2001 | CA2405779A1 Tamandarin and didemnin analogs and methods of making and using them |
| 10/18/2001 | CA2405568A1 Prion-binding peptidic ligands and methods of using same |
| 10/18/2001 | CA2405476A1 Compounds and methods for modulating endothelial cell adhesion |
| 10/18/2001 | CA2404290A1 Ternary ligand complexes useful as radiopharmaceuticals |
| 10/17/2001 | EP1144634A2 Novel complex-forming proteins |
| 10/17/2001 | EP1144446A1 Pharmaceutical compounds for the inhibition of hepatitis c virus ns3 protease |
| 10/17/2001 | EP1144437A1 Transcription factor e2f dna-binding domain inhibitor peptides and their use |
| 10/17/2001 | EP1144011A2 Prodrug compounds and process for preparation thereof |
| 10/17/2001 | CN1317493A Preparing process and application of undecapeptide |
| 10/17/2001 | CN1073117C Antibiotic peptide and prodn. method and use thereof |
| 10/17/2001 | CN1073116C Metal-bonding cystein-free peptides, process for producing them and its pharmaceutical preparation |
| 10/16/2001 | US6303576 Contacting cell with modulating agent that comprises internalization moiety and compound having amino acid sequencel peptide analogue or peptidomimetic of compound which retains ablity to inhibit beta-catenin mediated response |
| 10/16/2001 | US6303575 Indolicidin analogs and methods of using same |
| 10/16/2001 | US6303573 Heart homing peptides and methods of using same |
| 10/16/2001 | US6303319 Cell based assay for identifying sh2-domain-specific signal transducer antagonist |
| 10/16/2001 | US6303317 Preferential amino acid sequence probe; for as a diagnostic detection tool |
| 10/16/2001 | US6303312 Modifying cell phenotype; medical research and therapy |
| 10/16/2001 | US6303123 Which bind and neutralize the hormone gnrh in vivo. |
| 10/16/2001 | US6303118 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 10/16/2001 | CA2144104C Peptide derivatives having binding activity to modified low density lipoprotein |
| 10/16/2001 | CA2036463C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines |
| 10/11/2001 | WO2001074888A1 A novel polypeptide-human beta-preprotachykinin 9 and a polynucleotide encoding the same |
| 10/11/2001 | WO2001074884A1 Dermacentor variabilis gaba-gated chloride channels |
| 10/11/2001 | WO2001074862A2 Method for the production of bacterial toxins |
| 10/11/2001 | WO2001074858A2 Methods for altering t cell activation |
| 10/11/2001 | WO2001074857A2 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 10/11/2001 | WO2001074850A1 Antibiotics tripropeptins and process for producing the same |
| 10/11/2001 | WO2001074849A2 Binding peptides for carcinoembryonic antigen (cea) |
| 10/11/2001 | WO2001074848A2 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 10/11/2001 | WO2001074846A2 Peptides mimicking the biological activity of steroid hormones and their uses |
| 10/11/2001 | WO2001074845A2 Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof |
| 10/11/2001 | WO2001074844A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 10/11/2001 | WO2001074768A2 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 10/11/2001 | WO2001045746A3 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 10/11/2001 | CA2405484A1 Immunodominant acetylcholine receptor alpha subunit peptides, complexes thereof with mhc class ii components and their use |
| 10/11/2001 | CA2405319A1 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 10/11/2001 | CA2405043A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 10/11/2001 | CA2405035A1 Improved method for the production of bacterial toxins |
| 10/11/2001 | CA2404869A1 Peptides mimicking the biological activity of steroid hormones and their uses |